We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

The Alkermes facility in Athlone.
Job Losses

130 jobs to go in Alkermes' Athlone facility

The company said the decision was made following a reduction in demand for certain pharmaceutical products.

PHARMACEUTICAL COMPANY ALKERMES has announced that it is to reduce its staff by between 100 and 130 over the next two years.

The company said the decision was made following a reduction in demand “for certain pharmaceutical products that have become generic or are nearing the end of their commercial life”.

The company hopes to achieve the jobs losses through a combination of natural attrition, voluntary redundancy and compulsory redundancy.

Headquartered in Dublin, Alkermes currently employs 440 people between Dublin and Athlone.

Local TD Denis Naughten said it was a “dark day” and the job losses would “take approximately €4 million in wages out of the local economy”.

The pharmaceutical plant was formally known as Elan, but the businesses were combined in September 2011.

Read: Elan’s Athlone unit to get $1bn in merger deal >

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Your Voice
Readers Comments
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.